Inhaled SNG001 (COPD)
For this study researchers are looking for volunteers who have COPD to take part in a study which is investigating a medication called SNG001. It contains Interferon-B which is a protein that occurs naturally in the body. One of its functions is to fight viruses. Interferon-B has been given to thousands of patients for other diseases e.g. multiple sclerosis.
Recent research has suggested that Interferon-B might protect the cells in the lungs from cold and flu viruses. The common cold virus is known to cause a worsening of COPD symptoms (exacerbation) in some individuals. It is hoped that one day SNG001 will be given as a treatment to people with COPD to prevent an exacerbation of symptoms caused by the common cold.
If you decide to take part you would be asked to attend Gartnavel General Hospital in Glasgow where the doctor will ask some questions about your health and may do a number of breathing tests and do a general physical exam.
After this visit, you will be asked to contact the study team as soon as you start to develop cold symptoms or if your COPD symptoms start to get worse. The team will contact you via text every morning to see if you think you have a cold or COPD symptoms have got worse. If you do develop symptoms you will go for a visit where you will be assessed to see if you are eligible for treatment.
If you would like to hear more about this study, please email email@example.com or call 01382 383235/383431.
To check your eligibility for this study please complete the short questionnaire below. If you wish to take part, please ensure that you register with SHARE on completion so that we can contact you.